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ABSTRACT: The recent advances in genetic engineering demand the development of conceptually new methods to prepare
and identify eﬃcient vectors for the intracellular delivery of diﬀerent nucleotide payloads ranging from short single-stranded
oligonucleotides to larger plasmid double-stranded circular DNAs. Although many challenges still have to be overcome, polymers
hold great potential for intracellular nucleotide delivery and gene therapy. We here develop and apply the postpolymerization
modiﬁcation of polyhydrazide scaﬀolds, with diﬀerent degree of polymerization, for the preparation of amphiphilic polymeric
vehicles for the intracellular delivery of a circular plasmid DNA. The hydrazone formation reactions with a mixture of cationic
and hydrophobic aldehydes proceed in physiologically compatible aqueous conditions, and the resulting amphiphilic
polyhydrazones are directly combined with the biological cargo without any puriﬁcation step. This methodology allowed the
preparation of stable polyplexes with a suitable size and zeta potential to achieve an eﬃcient encapsulation and intracellular
delivery of the DNA cargo. Simple formulations that performed with eﬃciencies and cell viabilities comparable to the current
gold standard were identiﬁed. Furthermore, the internalization mechanism was studied via internalization experiments in the
presence of endocytic inhibitors and ﬂuorescence microscopy. The results reported here conﬁrmed that the polyhydrazone
functionalization is a suitable strategy for the screening and identiﬁcation of customized polymeric vehicles for the delivery of
diﬀerent nucleotide cargos.
■ INTRODUCTION
The transfection of genetic material to the interior of the cells
continues to be a key challenge for chemical biology and
biomaterials science.1−10 Although great progress has been
made in recent years, the potential of gene therapy remains
fairly underexploited.8 Thousands of clinical trials have been
explored in the past decade, but only a few products have
reached the market, including Gendicine in China, Glybera in
the European Union, or the recently approved Luxturna in the
United States.4,6,8 Viral vectors still remain as one of the
techniques of choice for cell transfection and gene therapy due
to their eﬃcacy and partial cellular selectivity.1,11 However, the
application of modiﬁed viral containers for gene delivery
presents important problems such as the limited loading of viral
capsids, the considerable immunogenic responses against viral
proteins, the risk of fatal eﬀects, and the ethical- and biosafety-
related concerns.1,6,11 These issues have prompted chemists,
pharmacologists, and material scientists to develop synthetic
vectors that could go beyond the current hurdles of nonviral
vectors in the promising ﬁeld of gene delivery.5,6,12−14
Encouraging nucleic acid delivery properties have been
explored for diﬀerent molecules and materials such as lipids
and lipidomimetics,7,15−22 peptides,23−47 supramolecular as-
semblies,48−53 and polymers.24,45,54−68 However, synthetic gene
transporters still present several challenges such as the vector
stability in physiological conditions, the frequent oﬀ-target
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uptake, the high cytotoxicity, and the low activity in tissues and
nondividing cells. Among the entire collection of nonviral
vectors, polymers are of great interest as they can display
multivalent chemical motifs required for cell transfection and
can be easily produced in large scale. Therefore, diﬀerent
synthetic methodologies, including combinatorial strategies,
have been explored to prepare polymers for DNA and RNA
transfection.54,59,69−71 However, standard polymerization re-
actions are normally carried out in the presence of organic
solvents, and as a consequence, isolation and puriﬁcation steps
are always required before screening for biological activity.
Furthermore, in most of these examples, the monomer
composition strongly inﬂuences the ﬁnal structure of the
products after the polymerization reaction.72,73 The hydrazone
bio-orthogonal connection has been conﬁrmed as an excellent
and compatible chemical motif for the conjugation of chemical
functions in diﬀerent biomolecular templates.31,74−80 In this
regard, we have recently reported the use of the postpolyme-
rization functionalization of polyhydrazide polymers to aﬀord in
situ activated amphiphilic polymers for the delivery of small
interfering RNA (siRNA).63 However, it is well-known that the
intracellular nucleotide delivery mediated by synthetic nonviral
vectors is strongly dependent on the nature and also the size of
the transported cargo.6,81
Herein we report the development of the in situ generated
polyhydrazone amphiphilic polymers for the delivery of a larger
circular DNA plasmid in HeLa cells. In this work, we
demonstrate the importance of the length of the polymer to
accomplish the condensation and the delivery of nucleotides
with diﬀerent lengths. This was easily established thanks to the
versatility of this methodology to screen diﬀerent amphiphilic
polymers that can be straightforwardly obtained in physiolog-
ically compatible conditions and without any isolation or
puriﬁcation steps. Polyhydrazides of diﬀerent lengths were
prepared and condensed with cationic and hydrophobic
aldehydes to yield the corresponding amphiphilic polyhydra-
zones. These amphiphilic polymers were screened for the
intracellular delivery of a plasmid DNA encoding the enhanced
green ﬂuorescent protein (EGFP). The results reported here
highlight the adaptability of the strategy for the straightforward
functionalization of polymer backbones in aqueous conditions
and the potential application of the resulting polyhydrazones
for the customized delivery of biological relevant molecules
(Figure 1).
■ EXPERIMENTAL SECTION
Materials. Poly(acryloyl hydrazide) was synthesized according to
our previously reported protocols62,63 (see Supporting Information for
full details and characterization). 2-((Ethylthio)carbonothioyl)thio-2-
methylpropanoic acid (CTA) was synthesized according to protocols
described in the literature82 (see Supporting Information). The
aldehydes tested were either commercially available or synthesized
following reported protocols from the corresponding alcohols.18,63
Lipofectamine 2000 (LF), Penicillin−Streptomycin−Glutamine
Mix, Trypsin-EDTA solution, and Dulbecco’s Modiﬁed Eagle’s
Medium (4500 mg/L glucose, L-glutamine, sodium pyruvate, and
sodium bicarbonate) were purchased from Fisher Scientiﬁc. Fetal
bovine serum was purchased from Sigma-Aldrich. pEGFP-C1, a
plasmid of 4731 bp encoding for the EGFP gene (see Figure S9), was
obtained from Clontech. A 2.7 kb ﬂuorescein labeled plasmid (Label
IT Plasmid Delivery Control) was purchased from Mirus.
All other chemicals were purchased from Sigma-Aldrich, Fisher
Scientiﬁc, VWR, or Acros, and used without further puriﬁcation. All
solvents were reagent grade or above; purchased from Sigma-Aldrich,
Fisher Scientiﬁc, or VWR; and used without further puriﬁcation.
Conjugation of Poly(acryloyl hydrazide) with Aldehyde
Modulators. In a typical experiment, poly(acryloyl hydrazide) in
acetate buﬀer (100 mM, pH 3.0) was reacted with 6 equiv of diﬀerent
molar fractions of guanidinium aldehyde (T1) and a hydrophobic
aldehyde tail (Tm). For most experiments, 25 μL of a solution of
poly(acryloyl hydrazide) (37.2 mM, 15 μg/mL) in acetate buﬀer (100
mM, pH 3.0), 7.5 μL of a solution of Tm (223.2 mM) in dry DMSO,
and 17.5 μL of a solution of T1 (223.2 mM) in dry DMSO were mixed
to give a ﬁnal Pn monomer concentration of 18.6 mM with a molar
ratio χT1 = 0.70 and χTm = 0.30. This mixture was shaken at 60 °C for
2 h. PnT1
χTm
1‑χ polymers were used without further puriﬁcation for
HeLa cells transfection experiments.
In Vitro Screening for Plasmid Delivery. HeLa cells were
maintained in DMEM supplemented with 10% FBS and 1%
Penicillin−Streptomycin−Glutamine Mix at 37 °C/5% CO2/ 95%
humidity. One day before transfection, cells were seeded in 96-well
plates at a concentration of 50 000 cells/mL (100 μL/well).
Transfection was done by incubation of cells with 2.5 ng/μL of
pEGFP and diﬀerent concentrations (0.5−8 μg/mL) of the activated
polymers (PnT1
χTm
1‑χ). Activated polymers stock solutions were
prepared in DMSO/acetate buﬀer (v/v) as described above, right
before use. The solutions of PnT1
χTm
1‑χ/pEGFP polyplexes were
freshly prepared prior to the transfection experiments by mixing 10 μL
of the pEGFP solution (50 ng/μL in DMEM) and 35 μL of
Figure 1. Schematic representation of screening of polyhydrazones for plasmid delivery. Polyhydrazides of diﬀerent length (degree of polymerization
− DP) were reacted with diﬀerent combinations of a cationic and a hydrophobic aldehyde. The resulting amphiphilic activated polymers were
incubated with a plasmid DNA encoding the green ﬂuorescent protein (EGFP) to give rise to diﬀerent polyplexes that were screened for gene
delivery.
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PnT1
χTm
1‑χ solution in DMEM for 30 min. After the incubation, the
mixture was added to 155 μL of DMEM and homogenized by
pipetting. Fifty microliters of this solution were added to each well of
HeLa cells. Positive controls for transfection were prepared with
Lipofectamine 2000 (6.6 μg/mL of Lipofectamine 2000 and 2.5 ng/μL
pEGFP), and negative controls were untransfected cells and cells
incubated with the same amount of plasmid in the absence of any
carrier. After 4 h, transfection mixtures were replaced by 100 μL of
DMEM supplemented with 10% FBS and antibiotics. The ﬁnal
concentration of DMSO in each well was 0.125% (v/v). All
experiments were done in triplicate. EGFP expression was studied at
72 hpt by ﬂuorometry, epiﬂuorescence microscopy or ﬂow cytometry.
Fluorometry. Three days after transfection, cell culture medium
was replaced with PBS (137 mM NaCl, 2.7 mM KCl, 8 mM
Na2HPO4, 1.5 mM KH2PO4) and EGFP expression measured by
ﬂuorometry in a Tecan Inﬁnite F200Pro microplate reader (λex 489
nm; λem 509 nm).
Epiﬂuorescence Imaging of Transfected Cells. HeLa cells were
transfected following the procedure described above. Cells were
washed with PBS at 72 hpt and immediately imaged under the
microscope.
Quantitation of the Number of Transfected Cells by Flow
Cytometry. HeLa cells were transfected following the procedure
described above. Three days after transfection, cells were washed with
PBS, trypsinized with 100 μL of Trypsin-EDTA for 10 min at 37 °C,
and trypsin was neutralized with 100 μL of 2% FBS in PBS with 5 mM
EDTA. Cell clumps were broken by pipetting before analyzing on a
Guava easyCyte cytometer. EGFP ﬂuorescence was determined by
excitation at 488 nm and detection at 512 nm/18 nm. Data analysis
was performed with InCyte software included in GuavaSoft 3.2
(Millipore). For the analysis, cells with typical FSC and SSC
parameters were selected, and cells were considered EGFP positive
when ﬂuorescence signal was higher than that of the untransfected
cells. An increase in SSC and autoﬂuorescence was observed for the
cells incubated with the higher concentrations of the polymer/plasmid
complexes, probably due to the remains of these complexes associated
with the cell membrane, and it was taken into account for the gating
(Figure S3).
Cell Viability: MTT Assay. Toxicity of the polyplexes was studied
with a colorimetric MTT assay, in which metabolic activity of the cells
causes the reduction of MTT to formazan. HeLa cells were transfected
with the polyplexes prepared with diﬀerent concentrations of the
activated PnT1
χTm
1‑χ polymers (0.5−8 μg/mL) and 2.5 ng/μL of
pEGFP. After 72 h of incubation, the medium was replaced by 100 μL
of fresh medium supplemented with 10 μL of MTT (5 mg/mL stock
solution in PBS), and further incubated for 4 h at 37 °C. The medium
was carefully aspirated and the purple precipitate of formazan was
dissolved with DMSO (100 μL/well). Absorbance at 570 nm was
measured in a Tecan microplate reader. Values were normalized
against untreated cells (100%).
Cellular Uptake Mechanisms. To study the mechanism of
cellular uptake, HeLa cells growing in a 96 well plate were treated for
30 min with the following compounds diluted in DMEM without
serum or antibiotics: Dynasore (80 μM), chlorpromazine (30 μM),
methyl-β-cyclodextrin (5 mM), or EIPA (50 μM). For the incubation
at low temperature, another plate was placed on ice, and ice-cold
solutions were used for the washes and incubations. Cells were then
incubated with 8 μg/mL of the P80T1
0.7T5
0.3 polyplexes prepared with
a ﬂuorescein-labeled plasmid (2.5 ng/μL) in the presence of the same
amount of inhibitors for 1 h at 37 °C. After the incubation, cells were
washed twice with PBS and trypsinized. Trypsin was neutralized with
2% FBS in PBS containing 5 mM EDTA and cell-associated
ﬂuorescence was measured on a Guava EasyCyte cytometer using
488 nm excitation laser and detection at 512 nm/18 nm. Data analysis
was done with InCyte software. Cells with typical FSC and SSC
parameters were selected, and the median ﬂuorescence intensity was
calculated for each sample (MFI). Each condition was done in
triplicate. Fluorescence values were normalized to the uptake of the
untreated control (100%) after blank subtraction.
Epiﬂuorescence Images of Transfection Complexes. HeLa
cells were incubated with transfection complexes prepared with a
plasmid labeled with ﬂuorescein (2.5 ng/μL) and the PnT1
0.7T5
0.3 (8
μg/mL) in DMEM without FBS. After 4 h of incubation, cells were
washed and DMEM without phenol red supplemented with 10% FBS
and 1% antibiotics was added. Cells were imaged at diﬀerent times
after the addition of the complexes using an epiﬂuorescence
microscope. To remove noninternalized complexes, another set of
cells were washed at 1 or 6 hpt with a solution of 1 mg/mL heparin in
PBS three times for 2 min each, before adding DMEM without phenol
red supplemented with 10% FBS and 1% antibiotics and imaged
(Figure S8).
Statistical Analysis. Statistical analysis was done with R-
software.83 Data was analyzed with pairwise Student’s t test with
Bonferroni’s correction, and p-values <0.05 were considered
signiﬁcant.
Hydrodynamic Radius and ζ-Potential. Ten microliters of
activated polymers stock solutions in DMSO/acetate buﬀer at diﬀerent
concentrations (8−2 μg/mL ﬁnal concentration) were freshly mixed
with a solution of pEGFP plasmid at a ﬁxed concentration (2.5 ng/μL,
995 μL in water) and were incubated for 30 min before measuring. For
the measurement of the polymers alone, 995 μL of plasmid solution
was replaced by the same amount of bidistilled water. Bidistilled water
was ﬁltered through a membrane ﬁlter (0.45 μm) before use. Polyplex
size and ζ-potential were determined using Malvern Zetasizer Nano
ZS90. All experiments were done at 25 °C, and the mean values and
standard deviations were obtained from triplicates.
Gel Retardation Assay. Freshly prepared PnT1
0.7T5
0.3 were mixed
in DMEM with pEGFP at diﬀerent charge ratios (0.75, 1.5, 3, 6, 9 and
12) and incubated at room temperature for 30 min. The mixtures,
including a solution of the free plasmid at the same concentration,
were loaded into a 0.8% agarose gel containing 0.5 μg/mL ethidium
bromide in TAE buﬀer (40 mM Tris, 20 mM acetic acid, and 1 mM
EDTA). Electrophoresis was performed at 100 V for 15 min. Gels
were imaged under UV light using a GelDoc system (Bio-Rad).
Atomic Force Microscopy (AFM). Standard AFM measurements
were conducted in ambient atmosphere at room temperature in a Park
Systems NX-10. ACTA tips were used (silicon tips, nominal values:
spring constant = 40 N/m, frequency = 300 kHz, ROC less than 10
nm). Samples were prepared by incubating an 8 μg/mL solution of
P80T1
0.7T5
0.3 or P180T1
0.7T5
0.3 with 2.5 ng/μL of pEGFP in Milli-Q
water during 30 min. For AFM imaging, 30 μL of the sample was
dropped onto freshly exfoliated mica, and after 15 min, the mica was
thoroughly washed with Milli-Q water and dried under Argon Flow.
Sample Preparation for Electron Microscopy (TEM and
STEM). Freshly prepared activated polymers PnT1
0.7T5
0.3 were mixed
with pEGFP (2.5 ng/μL) at a polymer concentration of 8 μg/mL in
Milli-Q water. The mixture was incubated for 30 min and subsequently
pipetted onto carbon coated copper grids. After 10 min, the remaining
solution was removed with ﬁlter paper and thoroughly washed with
ultrapure water. Samples were imaged without staining or after staining
for 1 min with 10 μL of 2% phosphotungstic acid, followed by several
washes with Milli-Q water. TEM images were acquired on a ZEISS
Libra 200 FE Omega transmission electron microscope operating at
200 kV accelerating voltage. The same samples were measured by
SEM and STEM on a Zeiss FESEM Ultra Plus.
■ RESULTS
Design and Initial Screening. We synthesized three
poly(acryloyl hydrazides) with diﬀerent degree of polymer-
ization, namely n = 40, 80, and 180 (P40, P80 and P180,
respectively). These polymers were prepared following the
previously reported synthetic methodology as illustrated in
Figure S1.62,63 Brieﬂy, the required monomer (tert-butyl-2-
acryloylhydrazine-1-carboxylate) was prepared by standard acyl
transfer protocols, and the monomer was polymerized by
reversible addition−fragmentation (RAFT) polymerization and
puriﬁed by dialysis against Milli-Q water.63 Finally, the Boc-
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protected polymers were treated with triﬂuoroacetic acid,
neutralized with NaHCO3, dialyzed against Milli-Q water, and
lyophilized to aﬀord the ﬁnal polyhydrazides.63 The full
characterization of these polymers and corresponding poly-
hydrazones was carried out as described in our previous
work.62,63 The parent polyhydrazides were incubated with a
mixture of one cationic and one hydrophobic aldehyde in H2O/
DMSO (1:1) at 60 °C. This incubation in aqueous conditions
resulted in the corresponding amphiphilic polyhydrazones that
could be combined in situ with the plasmid DNA without
further puriﬁcation (Figure 2A). As previously reported, we
decided to ﬁx the cationic moiety to the guanidinium derivative
T1, as the pKa of the guanidinium group (pKa = 12.5)
guarantees its protonation and thus cationic character at
physiological pH.51,84 To identify preliminary pairs of
aldehydes suitable for further development, an initial screening
of plasmid transfection in HeLa cells was performed using
ﬂuorometry to quantify transfection eﬃciency (Figure 2). We
started evaluating similar conditions to the previously reported
siRNA transport by reacting the shorter polymer (P40) with the
guanidinium aldehyde (χT1 = 0.7) and four diﬀerent hydro-
phobic aldehyde tails, namely, isovaleraldehyde, decanal,
dodecanal, and oleic aldehyde (χTm = 0.3). The corresponding
activated polyhydrazone polymers were named as PnT1
χTm
1‑χ,
where n = degree of polymerization (DP) of the polyhydrazide
used, m (2−5) is used to identify the hydrophobic aldehyde
used, and χ is the molar fraction of the guanidinium aldehyde in
the incubation mixture (Figure 2). Although an excess of
Figure 2. Polyhydrazone reaction, transfection scheme, and initial screening. (A) Schematic representation of polyplex formation through the
reaction between the polymer with n hydrazides sites Pn with the cationic T1 and the hydrophobic T5 to aﬀord the amphiphilic polyhydrazone
PnT1
χT5
1‑χ that is then combined with the plasmid DNA for polyplex formation and analysis (the χ superindex corresponds to the molar fraction of
the guanidinium aldehyde tail). (B) Scheme of the transfection experiments: after the uptake of the polyplex the DNA plasmid reaches the cell
nucleus and the consequent expression of the enhanced green ﬂuorescent protein (EGFP) can be quantiﬁed by ﬂuorometry. (C) Relative
ﬂuorescence (λex 489 nm; λem 509 nm) of HeLa cells transfected with P40 reacted with diﬀerent hydrophobic tails, measured at 72 hpt. Lipofectamine
(LF) was used as a positive control. Error bars indicate the standard deviation of three replicates. (D) Microscopy images of HeLa cells incubated
with pEGFP and 6 μg/mL of P40T1
0.7Tm
0.3 at 72 hpt. The corresponding hydrophobic aldehydes are indicated above each panel.
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aldehyde reactants was employed to maximize hydrazone
formation, several control experiments have fully conﬁrmed
that aldehydes alone do not transfect cells.18,40,42,63 After
hydrazone formation, the amphiphilic polymer was incubated
with the plasmid DNA in DMEM medium to form polyplexes
via electrostatic interactions. The selected cargo (pEGFP) was
a double-stranded circular plasmid DNA of 4.7 kilobases that
includes promoter, EGFP coding sequence, polyadenylation
sequences, and bacterial backbone (see supporting info).
In contrast to previous results observed for siRNA
transfection where P40 polymer showed excellent transfection
activity, these preliminary pEGFP delivery experiments
revealed only traces of protein expression for the combination
of P40 with the cationic T1 and the long unsaturated
hydrophobic oleic aldehyde (T5, Figure 2C).
40,42 The poor
transfection eﬃciency of the polyhydrazones derived from P40
combined with the larger DNA plasmid was conﬁrmed by
ﬂuorescence micrographs, which showed a small number of
green ﬂuorescent cells 72 h post-transfection (Figure 2D).
DNA Complexation and Polyplex Formation. The low
initial transfection eﬃciencies for P40 prompted us to further
investigate in detail the impact of the polyhydrazide length for
plasmid condensation and delivery. Based on the preliminary
results with P40 (Figure 2C) and on previously reported
successful examples for long unsaturated hydrophobic tails,40,42
we decided to ﬁx the hydrophobic tail to the oleic aldehyde for
the subsequent optimization. Therefore, following described
protocols,62,63 P40, P80, and P180 were condensed with a ﬁxed
molar ratio of aldehydes of χT1 / χT5 = 0.7:0.3. After the
reaction, the corresponding amphiphilic polyhydrazones were
directly combined with the plasmid DNA, and the resulting
polyplexes were studied by gel electrophoresis and dynamic
light scattering (DLS) (Figure 3). As shown by the gel
electrophoresis experiments, the shorter P40T1
0.7T5
0.3 failed to
complex the plasmid, whereas the medium and the longer
polyhydrazones, P80T1
0.7T5
0.3 and P180T1
0.7T5
0.3, eﬃciently
complexed the larger circular double-stranded DNA (Figure
3A). The DLS analysis of these amphiphilic polyhydrazones
conﬁrmed the formation of polyplexes with sizes between 70
and 100 nm (Figure 3B). The size and the zeta potential
progressively increased with increasing concentrations of the
polymers, and in agreement with the gel experiments, only the
medium and the large polyhydrazones, P80T1
0.7T5
0.3 and
P180T1
0.7T5
0.3, respectively, were able to aﬀord polyplexes with
the suﬃcient positive zeta potential of around 40 mV to stop
DNA gel migration (Figure 3A,B).
Figure 3. Gel retardation assay, DLS, and ζ-potential. (A) Gel retardation assay with the three polyhydrazones PnT1
0.7T5
0.3. pEGFP (lane 1) and
PnT1
0.7T5
0.3/pEGFP polyplexes with diﬀerent concentrations of polyhydrazones: 0.5 (lane 2), 1 (lane 3), 2 (lane 4), 4 (lane 5), 6 (lane 6), and 8 μg/
mL (lane 7). [pEGFP] = 2.5 ng/μL. (B) Hydrodynamic diameter in nanometers (nm) by dynamic light scattering (DLS) and zeta potential (ζ) in
millivolts (mV) of pure PnT1
0.7T5
0.3 and PnT1
0.7T5
0.3/pEGFP polyplexes at 2, 4, 6, and 8 μg/mL of polyhydrazone, measured in water. [pEGFP] =
2.5 ng/μL. Data is expressed as mean of triplicates; error bars indicate standard deviation.
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Transfection Optimization and Cell Viability. Having
conﬁrmed the formation of polyplexes with a suitable size and
zeta potential for the medium and longer polyhydrazides (P80
and P180), we next evaluated the pEGFP plasmid transfection
ability of the three polymers in HeLa cells (Figure 4). In these
experiments, the cells were incubated with the polyplexes
resulting from the reaction of the three diﬀerent polyhydrazides
(P40, P80, and P180) with T1 and T5. We started by performing
an optimization of the molar fraction of both aldehydes for the
polymer P80 (Figure 4B), conﬁrming the optimal cationic/
hydrophobic molar fraction to be χT1/χT5 = 0.7:0.3 (Figure
4B), a value slightly higher than the previously reported for
siRNA transfection.63 With this ﬁxed molar ratio, dose−
response transfection experiments were carried out with
increasing amounts of the three diﬀerent amphiphilic polymers
(Figure 4C). An increase in transfection eﬃciency with higher
polymer concentrations was observed for the three polymers.
As expected, the shorter polyhydrazone P40 that was not able to
eﬃciently condense the DNA transfected less than 10% of the
cells even at the highest concentration. Cytometry quantiﬁca-
tion of the transfection eﬃciency of the medium and the longer
polyhydrazones (P80 and P180) showed signiﬁcantly higher
levels of eﬃcacy than P40, above 20%, and at similar levels of
transfection eﬃciency observed for the commercial vector
Lipofectamine 2000 at a similar weight concentration (Figure
4C). Fluorescence microscopy images of cells transfected with
the P80T1
0.7T5
0.3 polyhydrazone visually conﬁrmed a good
eﬃcacy of the longer polymeric gene vector (Figure 4A). A
dose−response MTT colorimetric assay was then carried out to
study cell viability in the presence of the polyhydrazones at the
working conditions of the transfection experiments (Figure
4D). These experiments established a slightly better cell
viability and thus slightly lower toxicity for the transfecting
polyhydrazones in comparison with the control with the
Lipofectamine 2000 commercial vector.
Polyplex Microscopy Characterization. To further
investigate the size and shape of the polyplexes, we performed
a microscopic characterization of the transfecting polymer/
plasmid nanostructures reported in this study (Figures 5, S5−
S7). Nonstained scanning electron microscopy (SEM) micro-
graphs on Formvar/carbon grids of the shorter polymer
P40T1
0.7T5
0.3 polyplexes with pEGFP showed amorphous
aggregated materials, an observation that sustained the poor
transfection eﬃciency observed for this polymer length (Figure
2, Figure 4 and S3). This aggregation could indicate the lack of
the required electrostatic repulsion between the complexes to
stabilize individual particles. Analogous SEM micrographs for
P80T1
0.7T5
0.3 and P180T1
0.7T5
0.3 combined with the plasmid
DNA, showed particles of irregular globular shape, with a radius
of around 40 nm (Figures 5C,D and S5). Atomic force
microscopy (AFM) micrographs of P80T1
0.7T5
0.3 polyplexes
deposited on mica surfaces showed particles with heights of
around 20 nm (Figures 5B and S6). These low sizes obtained in
AFM could be explained by a possible collapse of the cationic
particles in the anionic mica surface, a situation that could cause
the particle spreading over the hydrophilic surface employed for
the atomic force microscopy. In an eﬀort to clarify the
diﬀerences in size from DLS and SEM, we acquired
transmission electron microscopy (TEM) images after staining
the fresh deposited sample with phosphotungstic acid followed
Figure 4. Transfection optimization and cell viability. (A) Bright-ﬁeld images, green ﬂuorescent channel and superimposed images of HeLa cells 3
days after transfection with polyplexes formed with 8 μg/mL of P80T1
0.7T5
0.3 and 2.5 ng/μL pEGFP. (B) Molar ratio optimization for the
transfection of plasmid DNA (2.5 ng/μL) with P80T1
χT5
1‑χ (8 μg/mL). Data is expressed as the mean of the percentage of transfected cells in three
replicates. Error bars indicate standard deviation. (see also Figure S2). (C) Transfection eﬃciency of the polymers P40T1
0.7T5
0.3, P80T1
0.7T5
0.3, and
P180T1
0.7T5
0.3 at diﬀerent concentrations. pEGFP concentration was kept constant at 2.5 ng/μL. Data is expressed as the mean of the percentage of
transfected cells in three independent transfection experiments. Error bars indicate standard deviation. The asterisk indicates a signiﬁcant diﬀerence
with a p-value of <0.05; n.s. indicates not signiﬁcant (Student’s t test with Bonferroni’s correction) (see Figures S3 and S4). (D) MTT viability assay.
HeLa cells were transfected with the indicated concentrations of the polymers P40T1
0.7T5
0.3 (gray bars), P80T1
0.7T5
0.3 (red bars) and P180T1
0.7T5
0.3
(black bars), and 2.5 ng/μL of plasmid, and 3 days after transfection, cell viability was measured with a MTT colorimetric assay. Values were
normalized to untreated cells and expressed as mean and standard deviation of three replicates. In all cases, Lipofectamine 2000 (LF) was used at 6.6
μg/mL as recommended by the supplier.
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by several washes of the microscopy grid with Milli-Q water.
The stained images of the polyplexes from P80 and P180
polyhydrazones showed the presence of particles with higher
diameters (∼70 nm) and with irregular globular shape (Figures
5E and S7). The diﬀerence in size of the polyplexes obtained by
electron microscopy (∼70 nm) and DLS measurements (∼90
nm) could be an eﬀect of the desiccation and shrinkage of the
polyplexes on the grid surface required for TEM studies,
combined with the potential solvation sphere of the particles
(Figures 3B and 5A).85 Finally, scanning transmission electron
microscopy (STEM) was carried out to investigate the
polyplexes and conﬁrm the presence of the DNA in the
organic nanoparticles (Figure 5F). The energy-dispersive X-ray
microanalysis of the nanoaggregates, prepared in Milli-Q water
(see Experimental Section), conﬁrmed the presence of nitrogen
(N) and phosphorus (P) in the polyplexes of P80T1
0.7T5
0.3 and
P180T1
0.7T5
0.3. The presence of these two atoms conﬁrmed the
condensation of the plasmid within the organic nanoparticles
observed by electron microscopy.
Mechanistic Studies and Fluorescent Plasmid Track-
ing. We carried out transfection experiments with a
ﬂuorescently labeled plasmid (CF-plasmid, CF: carboxyﬂuor-
escein dye) to study the internalization mechanism of the
polyplexes and to track the plasmid by ﬂuorescence microscopy
time-lapse images (Figure 6). In these experiments, the uptake
of the CF-plasmid was quantiﬁed by ﬂow cytometry in the
presence or absence of endocytic inhibitors (Figure 6B). As
expected for polyplexes of nanometric dimension and positive
zeta potential, the uptake was strongly reduced at low
temperature (4 °C), indicating an energy-dependent internal-
ization pathway of the polyhydrazone/plasmid organic nano-
particles (Figure 6B). Dynasore, an inhibitor of macro-
pinocytosis and all the internalization pathways that employ
dynamin to release endosomes in the cytosol, reduced the
polyplex uptake to a similar level as that obtained under low-
temperature conditions (4 °C). Additionally, three inhibitors of
speciﬁc endocytic mechanismschlorpromazine for clathrin-
mediated endocytosis, methyl-β-cyclodextrin for caveolae
mediated endocytosis, and EIPA for macropinocytosis
showed partial or strong inhibitory eﬀects in the uptake of
the polyplexes. All in all, these experiments suggested a
macropinocytic route in combination with other endocytic
Figure 5. Characterization of the active polyplexes. (A) Scheme for the active polyplexes composed of the core of polymer/DNA complex observed
in microscopy (∼60−70 nm) that in the aqueous dispersion gives rise to bigger solvated suspended nanoparticles (80−100 nm). (B) AFM
characterization of P80T1
0.7T5
0.3/ pEGFP deposited on mica surfaces. (C,D) Scanning electron microscopy (SEM) images of the polyplexes
P80T1
0.7T5
0.3 / pEGFP (C) and P180T1
0.7T5
0.3 / pEGFP (D) deposited in electron microscopy grids. (E) Transmission electron microscopy (TEM)
images P180T1
0.7T5
0.3 / pEGFP polyplexes deposited in electron microscopy grids and stained with of 2% phosphotungstic acid, followed by several
washes with Milli-Q water. (F) Example of Scanning transmission electron micrograph (STEM) and energy-dispersive X-ray microanalysis depicting
the presence of nitrogen (N) and phosphorus (P) in a polyplex of P180T1
0.7T5
0.3/ pEGFP. In Figure 5C−E, the scale bar is 100 nm. In all these cases,
polyplexes were prepared in Milli-Q water.
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mechanisms that could be operating at the same time for the
uptake of the polyhydrazone/plasmid nanoparticles. We next
carried out a ﬂuorescence microscopy time-lapse experiment in
cells to study internalization kinetics. In these experiments, the
ﬂuorescently labeled polyplexes were incubated with the cells
for 4 h, carefully washed with medium, and further incubated in
complete medium for microscopy analysis (Figures 6C and S8,
see Supporting Information). The images showed a low level of
membrane cellular attachment and a marginal signal of
punctuated endosomes for the polyplexes made with
P40T1
0.7T5
0.3. However, the polyplexes of P80T1
0.7T5
0.3 and
P180T1
0.7T5
0.3 showed a strong ﬂuorescence signal located at the
cell membrane level that increased until 6 h post transfection.
As expected, the cellular punctate ﬂuorescence signal from the
endosomes was visible 1 h post-transfection. Intriguingly, this
ﬂuorescence signal was still present after 4 days, indicating that
the polyplexes remained attached to the cell surface or
internalized into endosomal compartments after long incuba-
tion times (Figure 6C). Analogous experiments were
performed introducing extensive heparin washes to remove
externally bound polyplexes. These experiments reduced the
amount of ﬂuorescent signal associated with the cells, indicating
the presence of extracellular or membrane-bound particles, and
showed that these polyplexes, in cell culture medium, tend to
aggregate on the cell surface during the ﬁrst hours (Figure S8).
■ DISCUSSION
The emergence of new techniques in gene therapy such as
mRNA treatments, RNA interference, and genome editing
demands the development of conceptually new methodologies
for the nonviral transfection of diﬀerent nucleotide cargos. The
objective of this work was to demonstrate the versatility of the
in situ modiﬁcation of polymeric scaﬀolds63 to deliver diﬀerent
nucleotide cargos inside cells. In particular, we wanted to
Figure 6. Uptake Mechanism and Plasmid Tracking. (A) Scheme for mechanistic studies. Polyplexes were prepared with a ﬂuorescently labeled
plasmid (CF-plasmid). (B) Polyplex internalization mechanism. HeLa cells were incubated with the polyplexes formed by CF-plasmid and
P80T1
0.7T5
0.3 in the absence or presence of endocytosis inhibitors and the uptake of the labeled plasmid was quantiﬁed by ﬂow cytometry. Data is
expressed as median ﬂuorescence intensity normalized to the uptake of the polyplex by the untreated control (AP80), error bars indicate standard
deviation of three replicates. (C) Time-lapse epiﬂuorescence microscopy of the three polyplexes from the diﬀerent-length polyhydrazones
(PnT1
0.7T5
0.3, n = 40, 80 and 180) with the ﬂuorescently labeled CF-plasmid in HeLa cells. [PnT1
0.7T5
0.3] = 8 μg/mL, [CF-plasmid] = 2.5 ng/μL.
Cells were imaged at diﬀerent times (1 and 6 hpt, 1 and 4 dpt). hpt: hours post-transfection, dpt: days post-transfection. Nuclei were counterstained
with Hoechst (blue). See also Supporting Information.
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demonstrate that the recently reported methodology for the
delivery of small siRNA63 could be adapted to the more
challenging delivery of plasmid DNA. In the latter application,
the size of the nucleic acid is signiﬁcantly increased; however,
the delivery vehicle should be able to facilitate the transport of
the desired cargo to the nuclei. For this purpose, in this work
we synthesized polyhydrazides with diﬀerent degree of
polymerization that have been reacted with cationic and
hydrophobic aldehydes to prepare the corresponding poly-
hydrazone amphiphiles. These activated polymers were
combined with a DNA plasmid to study their capacity to
complex the nucleic acid and produce stable polyplexes of
suitable size and zeta potential for cell transfection. In contrast
to previous results with siRNA,63 we observed that short
cationic amphiphilic polyhydrazones, derived from the
polyhydrazide P40, were not able to complex the much larger
plasmid anionic payload (Figure 2). This is in agreement with
observations that suggest that for the delivery of plasmid DNA
the formation of aggregates of an adequate size is critical for the
uptake, while in the case of siRNA, due to its smaller size, the
protection against enzymatic degradation is more important
than condensation.86 As a result of this lack of packing capacity,
the shorter amphiphilic polymer could not eﬃciently trans-
locate and deliver the lengthy nucleotide cargo across the cell
membrane (Figures 2 and 3). However, the medium (P80) and
long (P180) amphiphilic polyhydrazones, incorporating cationic
(T1) and long hydrophobic (T5) pendants, eﬃciently packed
and delivered the plasmid DNA inside living cells (Figure 4).
These polyplexes showed good transfection eﬃciencies at a
similar slightly lower range but with slightly better cell viabilities
than the current gold standard for plasmid cell delivery,
Lipofectamine 2000 (Figure 4). As previously observed for
siRNA delivery with poly(ß)-amino esters and polyethyleni-
mines,6,81 the results reported here clearly highlight the
importance of polymer length for plasmid transfection when
carrying longer nucleotides payloads. Although an eﬃcient
nucleotide encapsulation constitutes a fundamental require-
ment for the packing and protection of the DNA cargo, the
polyplex dissociation at the correct time and location
constitutes the key step for an eﬃcient delivery.6 In this
regard, it has been recently proposed that the release of
individual polymers from the transported polyplexes could have
important implications in the generation of escape routes for
the endocytic nucleotide payloads.61 The in situ modiﬁcation of
a parent polyhydrazide scaﬀold reported here oﬀers a unique
opportunity to screen for polymeric gene vectors, across a
consistent degree of polymerization and with diﬀerent
functionalities that could have important implications in
polyplex stability and thus cargo delivery. The mechanistic
studies with endocytic inhibitors suggested that although
macropinocytosis could be the main internalization pathway,
several other endocytic mechanisms might be operating at the
same time. However, the eﬃcient plasmid expression observed
for the polyplexes of P80 and P180 unmistakably demonstrated a
release of the plasmid DNA from the endocytic vesicles and its
arrival into the cell nuclei. Altogether, the excellent DNA
packing capacity, the suitable transfection eﬃciency and cell
viability conﬁrmed the medium and larger polymers as suitable
polymeric vehicles for the transfection of large anionic cargos.
■ CONCLUSIONS
In summary, in this work we have demonstrated the potential
of hydrazone postpolymerization strategy to deliver plasmid
DNAs inside human cells. The strategy allowed us to quickly
extract important conclusions on the importance of the degree
of polymerization for plasmid condensation and delivery. In
contrast with the short siRNA (<25 base pairs), the larger
plasmid DNA (>4500 base pairs) required a longer polymer for
the eﬃcient DNA condensation, membrane translocation, and
nuclear delivery. The importance of this study builds on the
versatility of the strategy to perform a straightforward screening
and optimization of the polymer vector until the identiﬁcation
of the particular chemical and structural motifs required for the
transport of a particular cargo. Therefore, the possibility of
tuning the chemical properties of polymeric scaﬀolds with a
consistent degree of polymerization constitutes an excellent
alternative to identify potential customized vehicles for diﬀerent
cargos in a fully water-soluble and biocompatible methodology,
which does not require any isolation or puriﬁcation steps of the
ﬁnal compounds.
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received a Ramoń y Cajal (RYC-2013-13784), an ERC Starting
Investigator Grant (DYNAP-677786), and a Young Investigator
Grant from the Human Frontier Science Research Program
(RGY0066/2017). F. F.-T. thanks the Birmingham Science
City and the European Regional Development Fund, and the
University of Birmingham (John Evans Fellowship). J.M.P.
thanks the Spanish Agencia Estatal de Investigacioń (AEI) for
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(28) Palm-Apergi, C.; Lönn, P.; Dowdy, S. F. Do Cell-Penetrating
Peptides Actually “Penetrate” Cellular Membranes? Mol. Ther. 2012,
20 (4), 695−697.
(29) Koren, E.; Torchilin, V. P. Cell-Penetrating Peptides: Breaking
Through to the Other Side. Trends Mol. Med. 2012, 18 (7), 385−393.
(30) Stanzl, E. G.; Trantow, B. M.; Vargas, J. R.; Wender, P. A.
Fifteen Years of Cell-Penetrating, Guanidinium-Rich Molecular
Transporters: Basic Science, Research Tools, and Clinical Applications.
Acc. Chem. Res. 2013, 46 (12), 2944−2954.
(31) Montenegro, J.; Bang, E.-K.; Sakai, N.; Matile, S. Synthesis of an
Enlarged Library of Dynamic DNA Activators with Oxime, Disulfide
and Hydrazone Bridges. Chem. - Eur. J. 2012, 18 (33), 10436−10443.
(32) Nakase, I.; Akita, H.; Kogure, K.; Gras̈lund, A.; Langel, Ü.;
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